A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Polycythemia Vera
Related studies linked through entity extraction aliases.
AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms
- Status
- RECRUITING
- Phase
- PHASE3
An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety Evaluation Study for Patients With Polycythemia Vera
- Status
- UNKNOWN
- Phase
- PHASE1
Two Step Haplo With Radiation Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
A Study of LNK01002 in Patients With Primary or Secondary Myelofibrosis,Polycythemia Vera or Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib in Thrombocythemia and Polycythemia Vera
- Status
- RECRUITING
- Phase
- PHASE2
To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)
- Status
- COMPLETED
- Phase
- PHASE2
Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
- Status
- RECRUITING
- Phase
- PHASE2
IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera
- Status
- RECRUITING
- Phase
- PHASE3
Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)
- Status
- COMPLETED
- Phase
- PHASE2
Dual Vaccine Trial in Myeloproliferative Neoplasms
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase
- Status
- COMPLETED
- Phase
- NA
Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)
- Status
- COMPLETED
- Phase
- N/A
KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera
- Status
- UNKNOWN
- Phase
- PHASE2